EUVIMEDEUVIMED entdecken
Crossref

Decoding disease burden in multiple sclerosis: The role of IL-10 as biomarker of neuroinflammation and neurodegeneration

Eman M Khedr, Hussein Bahey El-Deen, Mohamed A El-Mokhtar, Doaa M Mahmoud

Multiple Sclerosis and Related Disorders · 2025

DOI: 10.1016/j.msard.2025.106540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis and Related Disorders, 2025. Verfasst von Eman M Khedr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt. Electronic address: Emankhedr99@yahoo.com. Hauptthemen laut MEDLINE: Interleukin-10, Chitinase-3-Like Protein 1, Multiple Sclerosis, Neuroinflammatory Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multiple sclerosis (MS) is a chronic neuroinflammatory disease with heterogeneous clinical presentations and progression rates that pose challenges to its management. Identifying prognostic biomarkers is crucial for individualized treatment approaches. Interleukin-10 (IL-10) has emerged as a key anti-inflammatory cytokine with neuroprotective effects, while Chitinase-3-like protein 1 (CHI3L1) reflects the pathogenic glial activation and neurodegeneration. OBJECTIVE: This study aimed to assess baseline serum IL-10 and CHI3L1 levels as biomarkers of disease burden and their correlation with clinical, cognitive, and quality-of-life (QoL) parameters in disease-modifying therapy (DMT)-naïve MS patients. METHODS: A cross-sectional, case-control study was conducted on 115 DMT-naïve MS patients and 15 healthy controls. Only 73 RRMS and 29 CIS confirmed MS participated in the study analysis. Serum IL-10 and CHI3L1 levels were measured using sandwich ELISA kits and were correlated with various demographic, clinical, motor, cognitive, and quality of life (QOL) parameters. RESULTS: Serum levels of IL-10 and CHI3L1 were significantly higher among MS patients compared to the healthy controls (P = 0.0001 for each one) and were negatively correlated with each other (r =-0.529 and P < 0.001). Second finding IL-10 levels negatively correlated with duration of disease (r = -0.389, P < 0.001), total number of relapse (r = -0.445, P < 0.001), motor disability (EDSS), Timed 25-Foot walk test (25-FWT), and depression scores (r = -0.398, P = 0.003, r = -0.340, P = 0.002 and r = -0.288, P = 0.008 respectively). It's positively correlated with most domains of QoL. CHI3L1 correlated positively with the total number of relapses (r = 0.253, P = 0.021), and EDSS (r = 0.346, P = 0.001), while negatively correlated with vitality, social, physical function, and general health domains of QoL (P = 0.009, 0.03, 0.001, and 0.013, respectively) CONCLUSION: IL-10 serves as a potential biomarker for disease burden in MS, with protective effects on QoL, highlighting its role in the early identification of favorable disease profiles and personalized disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Chitinase-3-Like Protein 1Multiple SclerosisNeuroinflammatory DiseasesCost of IllnessHumansFemaleMaleAdultBiomarkersCross-Sectional StudiesCase-Control StudiesMiddle AgedQuality of Life

Stichwörter der Autor:innen

Chitinase-3-like protein-1CognitionDMT-naïve multiple sclerosisInterleukin-10Motor disabilityQuality of life

Substanzen

Interleukin-10BiomarkersChitinase-3-Like Protein 1IL10 protein, humanCHI3L1 protein, human

Autor:innen und Institutionen

  • Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt. Electronic address: Emankhedr99@yahoo.com.
  • Department of Neurology and Psychiatry, Faculty of Medicine, South Valley University, Qena, Egypt. Electronic address: husseinbahey@med.svu.edu.eg.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt. Electronic address: lmokhtarma@aun.edu.eg.
  • Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt. Electronic address: Doaa_Mokhtar@med.aun.edu.eg.

Zitieren

APA

Khedr, E. M., El-Deen, H. B., El-Mokhtar, M. A., & Mahmoud, D. M. (2025). Decoding disease burden in multiple sclerosis: The role of IL-10 as biomarker of neuroinflammation and neurodegeneration. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2025.106540

Vancouver

Khedr EM, El-Deen HB, El-Mokhtar MA, Mahmoud DM. Decoding disease burden in multiple sclerosis: The role of IL-10 as biomarker of neuroinflammation and neurodegeneration. Multiple Sclerosis and Related Disorders. 2025. doi:10.1016/j.msard.2025.106540

BibTeX
@article{Khedr2025,
  author = {Khedr, Eman M and El-Deen, Hussein Bahey and El-Mokhtar, Mohamed A and Mahmoud, Doaa M},
  title = {Decoding disease burden in multiple sclerosis: The role of IL-10 as biomarker of neuroinflammation and neurodegeneration},
  journal = {Multiple Sclerosis and Related Disorders},
  year = {2025},
  doi = {10.1016/j.msard.2025.106540}
}
Kostenlos starten →